Clotrimazole/Betamethasone Dip
Brand name: Clotrimazole-Betamethasone
Rank #486 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$14.4M
Total Cost
503,015
Total Claims
$14.4M
Total Cost
17,644
Prescribers
$29
Cost per Claim
210,776
Beneficiaries
530,089
30-Day Fills
$817
Avg Cost/Provider
29
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$14.4M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $14.4M total
Top Prescribers of Clotrimazole/Betamethasone Dip
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Douglas Campbell | Podiatry | Brooklyn, NY | 982 | $41K |
| 2 | Navid Ezra | Dermatology | Thousand Oaks, CA | 148 | $31K |
| 3 | Ting Zhang | Podiatry | Flushing, NY | 762 | $27K |
| 4 | Yokaira Espiritusanto | Podiatry | Passaic, NJ | 350 | $25K |
| 5 | Edwin Valentin | Family Practice | Bayamon, PR | 877 | $21K |
| 6 | Drore Eisen | Dermatology | Cincinnati, OH | 658 | $19K |
| 7 | Duc Phan | Internal Medicine | Houston, TX | 267 | $18K |
| 8 | Xiandong Shi | Internal Medicine | Flushing, NY | 399 | $17K |
| 9 | Paul Ciavarelli | Podiatry | Opelika, AL | 538 | $16K |
| 10 | Hossam Amin | Pulmonary Disease | Brooklyn, NY | 369 | $15K |
| 11 | Jose Gonzalez | General Practice | Hialeah, FL | 378 | $15K |
| 12 | Roberto Abreu | General Practice | Utuado, PR | 363 | $15K |
| 13 | Mark Azbel | Internal Medicine | Brooklyn, NY | 321 | $14K |
| 14 | Natalia Maximovsky | Nurse Practitioner | Staten Island, NY | 248 | $14K |
| 15 | Zaven Arslanian | General Practice | Glendale, CA | 309 | $14K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 483 | Pazopanib Hcl (Votrient) | $14.5M | 1,156 |
| 484 | Exemestane (Exemestane) | $14.5M | 66,285 |
| 485 | Dihydroergotamine Mesylate (Dihydroergotamine Mesylate) | $14.4M | 6,855 |
| 486 | Clotrimazole/Betamethasone Dip (Clotrimazole-Betamethasone) | $14.4M | 503,015 |
| 487 | Verapamil Hcl (Verapamil Er) | $14.4M | 329,950 |
| 488 | Eteplirsen (Exondys-51) | $14.4M | 192 |
| 489 | Colesevelam Hcl (Colesevelam Hcl) | $14.3M | 50,268 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology